Biogen Idec (Nasdaq: BIIB) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced a collaboration to discover and develop RNAi therapeutics for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE